Wearable Artificial Kidney and Other New Treatment Options

This activity will include a unique insight from one of two research sites for testing the new Wearable Artificial Kidney technology. Participants will learn an overview of the technology, how the trials have gone and other future treatment research being done at the site. Moreover, participants will learn how to best determine a good candidate for the WAK technology, and the dietary recommendations to best compliment this treatment. 

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Summarize the history of sorbent-based and wearable dialysis technologies
  • Compare the Wearable Artificial Kidney (WAK) to current ESRD treatment options
  • Contrast current dietary recommendations for patients with ESRD with anticipated changes in diet with the WAK
  • List the three take home practices from this talk that attendees can utilize on their next working day

Target Audience

  • Dietitian
Accreditation/Designation of Credit Statements:


The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.


The activity is available for credit through July 26, 2019

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; complete the post-test (minimum score of 70% required) and evaluation to successfully earn credit.  The estimated time for completion is 1.5 hours. 

If you participated in the live symposium Wearable Artificial Kidney and Other New Treatment Options on Thursday, April 20, 2017 and claimed credit, you should not claim credit for this endured activity.

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.50 Attendance
  • 1.50 CDR CPEUs
Course opens: 
Course expires: 
Faculty Disclosures:

Jonathan Himmelfarb, MD
Director, Kidney Research Institute 
University of Washington
Seattle, WA
Disclosure: The speaker received an honoraria from Vertex as a consultant, and an honoraria from U.S. Renal Care as a speaker, both in the subject of kidney-on-a-chip.

Planning Committee Disclosures:

Beth Shanaman, RD
Registered Dietitian
Northwest Kidney Centers
Seattle, WA
Disclosure: Has no financial relationships with commercial interest(s).

Beth Morlang, RD, LD
Registered Dietitian
Central Florida Kidney Centers (Palm Bay)
Seattle, WA
Disclosure: Speakers’ Bureau: Keryx

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
Palm Bay, FL
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Available Credit

  • 1.50 Attendance
  • 1.50 CDR CPEUs


Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals